040-000-521 Rabeprazole Sodium
| Type | Active Pharmaceutical ingredient |
| Synonym | Pariprazole |
| CAS No. | 117976-90-6 |
| Chemical Formula | C18H20N3O3S · Na |
| Appearance | white powder |
| Packaging | 100mg, 1g, etc. |
| Assay | ≥98% |
| Related Products | Valsartan, Irbesartan, Olmesartan Medoxomil |
Description
Rabeprazole Sodium Introduction
Rabeprazole Sodium is a proton pump inhibitor class of anti-ulcer, the sodium salt form of rabeprazole. The so-called proton pump, H+/K+-ATPase, is the final link in gastric acid secretion. Proton pump inhibitors can effectively and quickly inhibit proton pumps and reduce gastric acid secretion. They are currently the most advanced drugs for the treatment of gastric and duodenal ulcers, reflux esophagitis, gastric Helicobacter pylori infection, and other digestive tract diseases. Compared with other types of acid-suppressing drugs, proton pump inhibitors have a strong acid-suppressing effect, high specificity, and long duration.
Rabeprazole Sodium Specification
| Appearance | white powder |
| Melting Point | 140-141℃ |
| Density | 1.50±0.1 g/cm3 |
| Content | 98.0% |
| Packaging | 100mg, 1g, etc. |
Rabeprazole Sodium Applications
Rabeprazole Sodium is a new drug for the treatment of gastric ulcers and can be used to treat peptic ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and other diseases.
